EQT Corp (NYSE: EQT) has shared early financial results for the second quarter of 2026, revealing a $45 million gain tied to its derivatives positions. This figure underscores the company’s efforts to manage exposure in an unpredictable energy market. The finalized numbers will be …
Ashtead Technology’s shares climbed after the company provided an optimistic full-year outlook, reinforcing confidence in the offshore energy sector. The move lifted sentiment among energy service providers, with investors betting on sustained demand for subsea equipment and inspection services.
The market opened lower as heightened geopolitical risk pushed Brent crude above $82 per barrel and sent the Nasdaq down 1.55% to 25,873. A steep rise in oil prices and a renewed focus on the Strait of Hormuz weighed on equities, particularly technology‑heavy indexes.
Oil prices jumped sharply after Iran announced that the Strait of Hormuz would be closed and the United States reinstated a blockade of Iranian vessels in mid‑July. The development propelled both crude and Brent contracts upward, while equity markets turned lower and Treasury yields …
Oil refiners are reaping unprecedented profits as a surge in crude supply clashes with persistent fuel shortages, sending refining margins to record highs.
Cheniere Energy Partners, L.P. (NYSE: CQP) has announced a significant leadership change with the appointment of Michael Jennings and Zamir Rauf to its Board of Directors. This move is expected to bring fresh perspectives to the company's operations in the natural gas and LNG …
Cheniere Energy, Inc. (NYSE: LNG) disclosed a governance update that adds a new seat to its board and introduces Britt Vitalone as a fresh independent director. The changes were formalized in mid‑July, reflecting the company’s ongoing efforts to strengthen oversight amid a dynamic energy …
ASML (AMS: ASML / NASDAQ: ASML) just did something it almost never does: raised full-year guidance for the second time in a single year, pushing 2026 sales to €43–45 billion from €36–40 billion, with gross margin climbing to 54–56% from 51–53%. The headline reaction …
Pluri Inc. (NASDAQ: PLUR) remains locked in negotiations with the European Investment Bank (EIB) over a €20 million loan repayment deadline, as the biotech firm seeks to avoid potential enforcement actions. The discussions, described as constructive, aim to resolve the loan’s terms before the …
Propanc Biopharma (NASDAQ: PPCB) confirmed a change to its board of directors. Long‑time director Annie Van Broekhoven stepped down, and the company named Carlo Campiciano as her successor.